Help
RSS
API
Feed
Maltego
Contact
Domain > www.monjuvihcp.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-06-05
104.18.8.99
(
ClassC
)
2026-02-08
162.159.142.37
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Wed, 31 Dec 2025 06:31:03 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Wed, 31 Dec 2025 07:31:03 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Wed, 31 Dec 2025 06:31:04 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-aliveCF-RAY: 9b67bb59cf9e1319-PDXCache-Control: max-age86400, publicx- !DOCTYPE html>html langen dirltr> head> meta charsetutf-8 />meta namedescription contentMONJUVI® (tafasitamab-cxix) is a targeted immunotherapy for use in R/R diffuse large B-cell lymphoma and R/R follicular lymphoma. See Full Prescribing information. />link relcanonical hrefhttps://www.monjuvihcp.com/ />link relshortlink hrefhttps://www.monjuvihcp.com/ />meta namegoogle-site-verification contentqgTMB9qUROnaLRsDX2blWYQxWI9mC51HZvJ2ieYx-Ew />meta nameGenerator contentDrupal 10 (https://www.drupal.org) />meta nameMobileOptimized contentwidth />meta nameHandheldFriendly contenttrue />meta nameviewport contentwidthdevice-width, initial-scale1.0 />script typeapplication/ld+json>{@context: https://schema.org/,@type: MedicalWebPage,specialty: https://schema.org/Oncologic,about: MONJUVI® for DLBCL and FL - Official HCP Site,url:https://www.monjuvihcp.com/,description: MONJUVI® (tafasitamab-cxix) is a targeted immunotherapy for use in R/R diffuse large B-cell lymphoma and R/R follicular lymphoma. See Full Prescribing information.,image: {@type: ImageObject,url:https://www.monjuvihcp.com/sites/g/files/hssmmz8411/themes/site/monjuvi-logo.png}}/script>script typeapplication/ld+json>{@context: https://schema.org/,@type: WebSite, name: MONJUVI® for DLBCL and FL - Official HCP Site,url: https://www.monjuvihcp.com/}/script>script typeapplication/ld+json>{@context:https://schema.org,@type:ItemList,itemListElement:{@type: SiteNavigationElement,position: 1,name: Diffuse LargeB-cell Lymphoma,url:https://www.monjuvihcp.com/dlbcl},{@type: SiteNavigationElement,position: 2,name: Follicular Lymphoma,url:https://www.monjuvihcp.com/fl}}/script>script typeapplication/ld+json>{@context:https://schema.org,@type: MedicalCondition,name: Diffuse large B-cell lymphoma,sameAs: https://en.wikipedia.org/wiki/Diffuse_large_B-cell_lymphoma, code: C83.3 }/script>script typeapplication/ld+json>{@context: https://schema.org,@type: MedicalIndication,name: Monjuvi (tafasitamab-cxix) INDICATION AND USAGE,description: MONJUVI (tafasitamab-cxix), in
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]